CORRECTED: Ciphergen Biosystems, Inc. Announces 1st Quarter 2003 Earnings and Web Cast Conference Call Details.Business Editors FREMONT, Calif.--(BUSINESS WIRE)--April 23, 2003 Ciphergen Biosystems, Inc. (NASDAQ NASDAQ in full National Association of Securities Dealers Automated Quotations U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on :CIPH CIPH Canadian Institute of Plumbing and Heating ), will announce its First Quarter 2003 Financial Results on Thursday, April 24, 2003, after market close. The announcement will be followed by a conference call at 11:00 a.m. (EDT EDT abbr. Eastern Daylight Time EDT Eastern Daylight Time EDT n abbr (US) (= Eastern Daylight Time) → hora de verano de Nueva York EDT ) on Friday, April 25, 2003, hosted by William E. Rich, President & Chief Executive Officer, and Matthew Hogan, Vice President and Chief Financial Officer. This call is being webcast by CCBN CCBN Central Coast Bancorp CCBN Charles County Business Network and can be accessed at Ciphergen's web site at www.ciphergen.com. Additionally, a telephone replay of the teleconference will be available for 24 hours Adv. 1. for 24 hours - without stopping; "she worked around the clock" around the clock, round the clock beginning at 2:30 p.m. (EDT) on Friday, April 25, and can be accessed by dialing Domestic: (800) 475-6701 or International (320) 365-3844, Access Code: 682722. About Ciphergen Ciphergen develops, manufactures and markets a family of ProteinChip(R) Systems and services for clinical, research and process proteomics applications, as well as a broad range of bioseparations media for protein purification through its BioSepra process chromatography division. ProteinChip Systems and Biomarker Discovery Center(R) collaborative services enable protein discovery, profiling, characterization and assay development to provide researchers with predictive analysis capabilities and a better understanding of biological functions at the protein level. ProteinChip Systems are enabling tools in the emerging field of protein-based biology research, known as proteomics. Proteomics provides a direct approach to understanding the role of proteins in the biology of disease, monitoring disease progression and evaluating the therapeutic effects and side effects Side effects Effects of a proposed project on other parts of the firm. of drugs. Ciphergen believes proteomics will be a major focus of biological research by enhancing the understanding of gene function and the molecular basis of disease. Additional information about Ciphergen can be found at www.ciphergen.com. |
|
||||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion